Knowledge of Stimulus Repetition Affects the Magnitude and Spatial Distribution of Low-Frequency Event-Related Brain PotentialsClementz B.A. · Barber S.K. · Dzau J.R.
Department of Psychology, University of California, San Diego, Calif., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Rate effects are defined as a reduction in amplitude of an evoked brain response with increasing stimulus frequency. In auditory paired-stimulus paradigms, a smaller amplitude evoked response to the second stimulus at a latency of 50 ms has been proposed to index a preattentive sensory gating mechanism. The present study investigated the possibility that expectancy and/or attentional biases could alter evoked potentials associated with rate effects. EEG data were recorded from 30 channels while subjects received 240 trials of 1, 2 or 3 click stimuli (with successive stimuli being separated by 500-ms intervals). Half of the subjects knew (blocked condition) and half of the subjects did not know (mixed condition) how many stimuli they would receive on a given trial. Subjects in the blocked condition had a significantly larger rate effect than subjects in the mixed condition. This effect was present only for low-frequency components of the event-related brain potential (ERP; below 10 Hz) and occurred from 30 to 60, 90 to 160 and 190 to 260 ms after stimulus presentation (P1-N1-P2 complex). Mixed condition subjects also had larger contributions to their ERPs from temporal channels. These results suggest that the rate effect can be significantly altered by expectancy, and they are inconsistent with the thesis that ERPs near 50 ms in a paired-stimulus paradigm solely index a preattentive sensory gating mechanism.
© 2002 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.